Hepatitis B virus inhibits liver regeneration via epigenetic regulation of urokinase-type plasminogen activator

Hepatology

Volumn 58, Issue 2, 2013, Pages 762-776

  Park, Eun Sook ^a   Park, Yong Kwang ^a   Shin, Chan Young ^a   Park, Seung Hwa ^a   Ahn, Sung Hyun ^a   Kim, Doo Hyun ^a   Lim, Keo Heun ^a   Kwon, So Young ^a   Kim, Kwang Pyo ^b   Yang, Sung Il ^a   Seong, Baik L ^c   Kim, Kyun Hwan ^a  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3A2; HEPATITIS B VIRUS X PROTEIN; KI 67 ANTIGEN; MESSENGER RNA; SCATTER FACTOR; UNCLASSIFIED DRUG; UROKINASE; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC REGULATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER REGENERATION; MALE; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRUS GENOME; VIRUS PATHOGENESIS;

ANIMALS; CELL LINE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA, VIRAL; EPIGENESIS, GENETIC; HEPATECTOMY; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; LIVER REGENERATION; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84881028811     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26379     Document Type: Article

References (48)

1. Feitelson MA. Hepatitis B virus in hepatocarcinogenesis. J Cell Physiol 1999;181:188-202.
2. Bréchot C, Gozuacik D, Murakami Y, Paterlini-Bréchot P. Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin Cancer Biol 2000;10:211-231.
3. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000;64:51-68.
4. Lucito R, Schneider RJ. Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol 1992;66:983-991.
5. Su F, Theodosis CN, Schneider RJ. Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J Virol 2001;75:215-225.
6. Tanaka Y, Kanai F, Ichimura T, Tateishi K, Asaoka Y, Guleng B, et al. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Oncogene 2006;25:633-642.
7. Chirillo P, Pagano S, Natoli G, Puri PL, Burgio VL, Balsano C, et al. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci U S A 1997;94:8162-8167.
8. Kim KH, Seong BL. Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal. EMBO J 2003;22:2104-2116.
9. Koike K, Moriya K, Yotsuyanagi H, Iino S, Kurokawa K. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J Clin Invest 1994;94:44-49.
10. Benn J, Schneider RJ. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci U S A 1995;92:11215-11219.
11. Tralhao JG, Roudier J, Morosan S, Giannini C, Tu H, Goulenok C, et al. Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver proliferation: an alternative mechanism of HBx-related pathogenesis. Proc Natl Acad Sci U S A 2002;99:6991-6996.
12. Wu BK, Li CC, Chen HJ, Chang JL, Jeng KS, Chou CK, et al. Blocking of G1/S transition and cell death in the regenerating liver of hepatitis B virus X protein transgenic mice. Biochem. Biophys Res Commun 2006;340:916-928.
13. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997;276:60-66.
14. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006;43:S45-S53.
15. Michalopoulos GK. Liver regeneration: molecular mechanisms of growth control. FASEB J 1990;4:176-187.
16. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004;5:836-847.
17. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007;213:286-300.
18. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. J Hepatol 2012;57:692-694.
19. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992;11:4825-4833.
20. Mars WM, Zarnegar R, Michalopoulos GK. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 1993;143:949-958.
21. Birchmeier C, Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 1998;8:404-410.
22. Pediaditakis P, Lopez-Talavera JC, Petersen B, Monga SP, Michalopoulos GK. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology 2001;34:688-693.
23. Myohanen H, Vaheri A. Regulation and interactions in the activation of cell-associated Plasminogen. Cell Mol Life Sci 2004;61:2840-2858.
24. Danø K, Rømer J, Nielsen BS, Bjørn S, Pyke C, Rygaard J, et al. Cancer invasion and tissue remodeling-cooperation of protease systems and cell types. APMIS 1999;107:120-127.
25. Behrendt N. The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling. Biol Chem 2004;385:103-136.
26. Rabbani SA, Mazar AP. The role of the plasminogen activation system in angiogenesis and metastasis. Surg Oncol Clin N Am 2001;10:393-415.
27. Swaisgood CM, French EL, Noga C, Simon RH, Ploplis VA. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol 2000;157:177-187.
28. Shimizu M, Hara A, Okuno M, Matsuno H, Okada K, Ueshima S, et al. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis. Hepatology 2001;33:569-576.
29. Zhang G, Kim H, Cai X, López-Guisa JM, Alpers CE, Liu Y, et al. Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 2003;14:1254-1271.
30. Luikart SD, Levay-Young B, Hinkel T, Shearer J, Mills C, Caldwell MD, et al. Mactinin treatment promotes wound healing-associated inflammation in urokinase knockout mice. Wound Repair Regen 2006;14:123-128.
31. Roselli HT, Su M, Washington K, Kerins DM, Vaughan DE, Russell WE. Liver regeneration is transiently impaired in urokinase-deficient mice. Am J Physiol 1998;275:G1472-1479.
32. Yang PL, Althage A, Chung J, Chisari FV. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci U S A 2002;99:13825-13830.
33. Mitchell C, Willenbring H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc 2008;3:1167-1170.
34. Ibañez-Tallon I, Ferrai C, Longobardi E, Facetti I, Blasi F, Crippa MP. Binding of Sp1 to the proximal promoter links constitutive expression of the human uPA gene and invasive potential of PC3 cells. Blood 2002;100:3325-3332.
35. Bouchard MJ, Wang LH, Schneider RJ. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 2001;294:2376-2378.
36. Arakaki N, Kawakami S, Nakamura O, Ohnishi T, Miyazaki H, Ishii T, et al. Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases. Hepatology 1995;22:1728-1734.
37. Liu ML, Mars WM, Michalopoulos GK. Hepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamine. Carcinogenesis 1995;16:841-843.
38. Shiota G, Rhoads DB, Wang TC, Nakamura T, Schmidt EV. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci U S A 1992;89:373-377.
39. Santoni-Rugiu E, Preisegger KH, Kiss A, Audolfsson T, Shiota G, Schmidt EV, et al. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc Natl Acad Sci U S A 1996;93:9577-9582.
40. Wang Z, Ge L, Wang M, Carr BI. Grb2-associated binder-1 plays a central role in the hepatocyte growth factor enhancement of hepatoma growth inhibition by K vitamin analog compound 5. Hepatology 2007;46:2003-2013.
41. Hodgson AJ, Keasler VV, Slagle BL. Premature cell cycle entry induced by hepatitis B virus regulatory HBx protein during compensatory liver regeneration. Cancer Res 2008;68:10341-10348.
42. Jung JK, Arora P, Pagano JS, Jang KL. Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res 2007;67:5771-5778.
43. Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, et al. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 2007;132:1476-1494.
44. Zheng DL, Zhang L, Cheng N, Xu X, Deng Q, Teng XM, et al. Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. J Hepatol 2009;50:377-387.
45. Belloni L, Pollicino T, De Nicola F, Guerrieri F, Raffa G, Fanciulli M, et al. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci U S A 2009;106:19975-19979.
46. Suk KT, Kim DJ. Drug-induced liver injury: present and future. Clin Mol Hepatol 2012;18:249-257.
47. Lee SY, Kim HJ, Lee WJ, Joo SH, Jeon SJ, Kim JW, et al. Differential regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by the cyclic-AMP system in lipopolysaccharide-stimulated rat primary astrocytes. Neurochem Res 2008;33:2324-2334.
48. Shin SM, Cho KS, Choi MS, Choi MS, Lee SH, Han SH, et al. Urokinase-type plasminogen activator induces BV-2 microglial cell migration through activation of matrix metalloproteinase-9. Neurochem Res 2010;35:976-985.